Open AccessAbstract 2867: MDM2 and MDM4 are therapeutic vulnerabilities in malignant rhabdoid tumors
Author(s) -
Thomas P. Howard,
Taylor E. Arnoff,
Melinda R. Song,
Andrew O. Giacomelli,
Xiaofeng Wang,
Andrew L. Hong,
Neekesh V. Dharia,
Su Wang,
Francisca Vázquez,
Minh-Tam Pham,
Ann M. Morgan,
Franziska Wachter,
Gregory H. Bird,
Guillaume Kugener,
Elaine M. Oberlick,
Matthew G. Rees,
Hong L. Tiv,
Justin Hwang,
Katherine H. Walsh,
April Cook,
John M. Krill-Burger,
Aviad Tsherniak,
Prafulla C. Gokhale,
Peter J. Park,
Kimberly Stegmaier,
Loren D. Walensky,
William C. Hahn,
Charles W.M. Roberts
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-2867
Subject(s) - cancer research , mdm2 , biology , crispr , mutation , cell culture , cell growth , apoptosis , genetics , gene